NEW YORK – September 14, 2022 – ObvioHealth, a pioneering virtual research organization (VRO), announces the launch of ObvioGo, a next-generation decentralized clinical trial platform and mobile application powered to deliver stronger evidence of therapeutic efficacy and safety. While the pandemic … Read More
Medical personnel working on the frontline to prevent the spread of the COVID-19 (coronavirus) are susceptible to infection, we believe telemedicine can help to mitigate this risk. … Read More
Following our three successful past events – June 2017 & January 2019 in Singapore and April 2019 in New York – SPRIM held another exciting Ventures Day at our brand new auditorium in Singapore. Our CEOs, science/tech experts, and strategic innovators presented … Read More
The U.S. FDA is aware the drug approval process can often be strenuous, consuming large amounts of time and money. That’s why they’ve made a commitment to consider real-world data and evidence in the approval of new drug indications resulting in a more efficient approach for manufacturers. … Read More
From blockchain to 3D printing – we’ve pinpointed the biggest tech trends in health innovation and what they mean for healthcare in 2020. You’re likely familiar with many of these trends, however, advances in the industry have allowed for new applications … Read More
Forty percent of the world’s plastic usage comes from packaging – packaging of food, beverage, personal care, cosmetic, toys and almost every other product on store shelves. With the U.S. inefficiencies and China’s crackdown, reducing the amount of plastic that enters circulation is becoming increasingly important. … Read More
A breakdown of the four practices areas SPRIM utilizes to help its clients meet their commercial endpoints: strategy and innovation, regulatory and scientific affairs, research and clinical services and medical marketing and engagement. … Read More
The booming middle-class in Asia and the accompanying influx of consumer spending is an enticing area for companies looking to capitalize on. RegTech can reduce the regulatory obstacles that FMCG and medical device companies face when expanding, enabling them to bring their products to market in more efficient and cost-effective ways. … Read More
This article explains the emergence of RegTech as an opportunity in the consumer product goods industry, as food and beverage, personal care, pharmaceutical, and cosmetic companies often struggle to stay updated on the regulations in a region or country. … Read More
As media attention increases around the risk of “bad” products on the market, consumers are becoming increasingly wary of the presence of potentially harmful, misbranded dietary supplements. If this trend continues, we predict that customers will not only become more selective when buying products, but that overall trust in the industry will begin to weaken. So, how can dietary supplement companies selling legitimate products ensure they aren’t looped in with the bad apples? … Read More
Ayala Healthcare Holdings announced an investment in SPRIM’s portfolio company, Fibronostics. As part of the partnership, AC Health will launch two Fibronostics products, LiverFAST and HealthFACTR, in its FamilyDOC clinics in the Philippines. … Read More
“BYOD” or “bring your own device” is the future of clinical studies, and sponsors are embracing what will become the new standard. Subjects using their own devices to fill out diaries and input data is not only less expensive for … Read More
SPRIM has worked with dozens of Unilever brands on projects ranging from market rollouts and HCP engagement to business innovation. … Read More
Medicines don’t work if patients don’t take them. It’s one of the biggest culprits in healthcare’s nearly $300 billion problem. Estimates show poor adherence causes approximately 125,000 deaths and at least 10 percent of hospitalizations annually. Patient Engagement Programs Pharma companies are actively … Read More
The most common missteps SPRIM sees when working with clients to developing and bringing new products to the market. … Read More
SPRIM Ventures in partnership with Tikehau Capital is hosting a Ventures Day event in New York on April 24. … Read More
Fibronostics presented its corporate strategy at the second annual TKS 1 Investor Day in Singapore. The event was attended by current and potential investors in the TKS 1 fund, including venture capitalists, strategic investors, family offices and leaders from the healthcare industry. … Read More
Evid Science’s founder and CEO, Matt Michelson, spoke to Thrive Global about the future of healthcare and how AI is transforming the industry. Evid Science is helping to “free” all of the scientific data locked away in publications and journals. … Read More
Going strong in its second time, together with Tikehau Capital, SPRIM held TKS 1 Investor Day on Friday, January 25, 2019, at the Four Seasons Hotel in Singapore. We invited all teams, shareholders, and partners of the ventures for this event … … Read More
RegAsk uses artificial intelligence to answer regulatory questions, including inquiries about path-to-market, path-to-claim, product registration and regulatory strategy. … Read More
LOS ANGELES, CA (February 15, 2018) – Evid Science, an artificial intelligence (AI) company for the pharmaceutical industry, has successfully secured seed funding from TKS I, a new private equity fund dedicated to early-stage life science companies. “Our technology is … Read More
Intellectual property (IP) derived from discoveries made at Duke-NUS Medical School (Duke-NUS) have been licensed to a newly formed biotech start-up, Travecta Therapeutics Pte Ltd, a Singapore-based drug discovery company. Travecta plans to use the Duke-NUS technology to develop new … Read More
HONG KONG – Travecta Therapeutics Pte Ltd. is the latest startup to join Singapore’s biotech block. The newly formed drug discovery company is based on intellectual property derived from discoveries made at Duke-NUS Medical School (Duke-NUS). Travecta is based on … Read More
PHILADELPHIA — Sept. 13 2018 – Travecta Therapeutics, an emerging biotech company developing a platform that leverages its proprietary knowledge of the MFSD2a Transport for the targeted delivery of therapeutic agents across the blood-brain barrier, announces it has appointed Douglas … Read More
A R&D Guide Outlining Ways To Use E-commerce For A More Effective Analysis On A Future Product’s Success. … Read More
A Patient (and consultant’s) Point-of-View on Patient Services Imagine, as a patient, you leave the doctor’s office having been diagnosed with a chronic disease. The treatment calls for heavy doses of medication and changed lifestyle habits. You pestered the doctor … Read More
ObvioHealth, supported by SPRIM, releases a Mobile App that is positioned to transform clinical studies globally. … Read More
ORLANDO, Fla.–(BUSINESS WIRE)–ObvioHealth, a global medical technology company, announces the launch of its mobile application for site-less clinical studies— the ObvioHealth app. The app removes barriers currently troubling the clinical research industry by improving convenience for study subjects, enhancing compliance, … Read More
ObvioHealth, a Singapore and Orlando-based company offering mobile and “site-less” clinical trials, said on Friday it has raised US$3 million in Series A funding. The company is focused on making clinical trials faster and more cost-effective by digitizing the entire process … Read More